• A
  • A
  • A
日本語 Help
Science and technology information site for articles, patents, researchers information, etc.

Co-authoring Researcher

Co-inventing Researcher

Researcher similar to the Researcher

Article similar to the Researcher

Patent similar to the Researcher

Research Project similar to the Researcher

Article(J-GLOBAL estimation)

Patent(J-GLOBAL estimation)

Rchr
J-GLOBAL ID:201801014716254738   Update date: Apr. 09, 2025

TAKAHARA SHIZUKO

TAKAHARA SHIZUKO
Clips
Affiliation and department:
Research field  (4): Healthcare management, medical sociology ,  Web and service informatics ,  Biological, health, and medical informatics ,  Clinical psychology
Research theme for competitive and other funds  (5):
  • 2022 - 2024 N/A
  • 2017 - 2022 Acute and medium- to long-term effects of Asian dust and air pollutants on allergies and biomarker search
  • 2019 - 2022 Research on inter-institutional collaboration for promoting use of CDISC standard in academia
  • 2015 - 2019 アカデミアにおける臨床研究データ管理のCDISC準拠体制モデルの構築
  • ラミニンγ2単鎖測定による高悪性度膵がん診断、治療効果予測の前向き研究
Papers (15):
  • Takehiko Okamura, Kouji Izumi, Satoshi Kurokawa, Takashi Shima, Yuki Kato, Koji Mita, Manabu Kamiyama, Shogo Inoue, Seiji Hoshi, Nobumichi Tanaka, et al. Efficacy and Safety of Enzalutamide and Abiraterone Plus Prednisolone in Elder Castration-Resistant Prostate Cancer Patients: A Sub-Analysis From the ENABLE Study. The Prostate. 2025
  • 高原 志津子. CDISC標準の初学者向け学習動画. Precision Medicine. 2025. 8. 2. 104-107
  • Nobumichi Tanaka, Kouji Izumi, Yasushi Nakai, Takashi Shima, Yuki Kato, Koji Mita, Manabu Kamiyama, Shogo Inoue, Seiji Hoshi, Takehiko Okamura, et al. Dose modification in enzalutamide and abiraterone plus prednisolone for castration-resistant prostate cancer: A subanalysis from the ENABLE study for PCa. The Prostate. 2024
  • Anri Inaki, Atsushi Mizokami, Hiroshi Wakabayashi, Kouji Izumi, Yoshifumi Kadono, Tadashi Toyama, Shizuko Takahara, Toshinori Murayama, Seigo Kinuya. Evaluation of 68Ga-PSMA-11 PET/CT: a Phase 1 clinical study in Japanese patients with primary, recurrent, or suspected recurrent prostate cancer. Annals of Nuclear Medicine. 2024. 38. 8. 587-595
  • Yoshifumi Kadono, Hiroyuki Konaka, Takahiro Nohara, Kouji Izumi, Satoshi Anai, Kiyohide Fujimoto, Tomoyuki Koguchi, Kei Ishibashi, Noriyasu Kawai, Keita Nakane, et al. Efficacy and Safety of First-Line Cytokines Versus Sunitinib and Second-Line Axitinib for Patients with Metastatic Renal Cell Carcinoma (ESCAPE Study): A Phase III, Randomized, Sequential Open-Label Study. Cancers. 2023. 15. 10. 2745-2759
more...
MISC (1):
  • Shizuko Takahara, Nanayo Aoki, Kenkei Hasatani, Yasuhito Imai, Toshinori Murayama. A model of a hybrid system for randomization on that day. Japanese Pharmacology and Therapeutics. 2017. 45
Books (1):
  • 【eCTD、CDISCによる】医薬品承認申請と使用するデータの管理と信頼性確保
    技術情報協会 2019
Lectures and oral presentations  (28):
  • Examination of 42 Cases of Blunders in CDISC/SDTM in Physician-led/Industry-led Clinical Trials: Insights from the Field
    (2024 CDISC Japan Interchange 2024)
  • 既存情報の二次利用を伴う特定臨床研究の実施手続きにおける問題点
    (日本臨床試験学会第15回学術集会総会 2024)
  • 非臨床研究中核病院における多施設共同医師主導治験の実施体制の構築
    (日本臨床試験学会第15回学術集会総会 2024)
  • 医師主導/企業主導治験の現場におけるCDISC/SDTMにおける失敗(しくじった)事例42例の検討
    (日本臨床試験学会第15回学術集会総会 2024)
  • 無料EDCシステム「LibreClinica」の パソコン単体での運用方法
    (日本臨床試験学会第15回学術集会総会 2024)
more...
Education (2):
  • 2016 - 2022 Kanazawa University
  • 2011 - 2013 Kansai University Graduate School
Association Membership(s) (3):
日本メディカルAI学会 ,  CDISC Japan User Group ,  Japan Society of Clinical Trials and Research
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page